Migraine. Nervous system disorder NOS
Conditions
Interventions
Intervention 1: Intervention: ginger capsulet (500 mg powder of ginger) daily for 6 weeks. Intervention 2: Control: placebo capsulet (500 mg of pharmaceutical starch) daily for 6 weeks.
Treatment - Other
Placebo
Intervention: ginger capsulet (500 mg powder of ginger) daily for 6 weeks
Control: placebo capsulet (500 mg of pharmaceutical starch) daily for 6 weeks
Sponsors
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
76 Years to 37 Years
Inclusion criteria
Inclusion criteria: Inclusion major criteria: Diagnose of migraine by neurologist based on the International Headache Society (IHS) criteria; Aged 17-60 years; At least one year history migraine; 2-10 migraine per month exclusion major criteria: Patients with history of biliary disease or peptic ulcer; Allergy to ginger; Cardiovascular disease; Use of anticoagulant therapy; Secondary headaches due to head trauma; Use herbal medicines; Vitamin-mineral supplements; Pregnancy or Breastfeeding; Lack of cooperation in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum CRP levels. Timepoint: Baseline ,6 weeks after the intervention. Method of measurement: mg/dl by blood test.;Headache severity. Timepoint: Baseline ,6 weeks after the intervention. Method of measurement: Visual Analogue Scale.;Headache frequency. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: The frequency of migraine attacks per month by questionnaire.;Duration of headache. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: Based on minutes by questionnaire.;Frequency × Duration of headache. Timepoint: Baseline, 6 weeks after the intervention. Method of measurement: Calculation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Jahangosha
Isfahan University of Medical Sciences
Outcome results
None listed